Evidence map›Paper›PMID 33634830›Full record

ReviewJournal of rehabilitation medicine2021

Effect of neuromuscular electrical stimulation on the recovery of people with COVID-19 admitted to the intensive care unit: A narrative review.

Louise C Burgess, Lalitha Venugopalan, James Badger, Tamsyn Street, Gad Alon, Jonathan C Jarvis, Thomas W Wainwright, Tamara Everington, Paul Taylor, Ian D Swain

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Journal of rehabilitation medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05465291 nacompletednot on this mapstarted 2022, after this paper: background citation

Effect of Neuromuscular Electrical Stimulation and Early Physical Activity on ICU Acquired Muscle Weakness in Mechanically Ventilated Patient: A Randomized Controlled Trial

TypeinterventionalSponsorDamanhour UniversityRan2022 to 2023Enrolled120ConditionsNeuromuscular Electrical Stimulation, ICU Acquired Muscle WeaknessArmsExercise group, Neuromuscular Electrical Muscle Stimulation group, Neuromuscular Electrical Muscle Stimulation and Exercise group
NCT05681455 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Physiotherapy for Persistent Function by Superficial Neuromodulation

TypeinterventionalSponsorUniversidad Rey Juan CarlosRan2023 to 2023Enrolled24ConditionsPost-Acute COVID-19 Syndrome, Dysautonomia, NeuromodulationArmsNeuromodulation NESA NXSIGNAL® device
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Observational
  10. Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Skeletal Muscle Damage in COVID-19: A Call for Action.Medicina (Kaunas, Lithuania) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

Louise C BurgessOrthopaedic Research Institute, Bournemouth University, BH8 8EB Bournemouth, United Kingdom.
Lalitha Venugopalan
James Badger
Tamsyn Street
Gad Alon
Jonathan C Jarvis
Thomas W Wainwright
Tamara Everington
Paul Taylor
Ian D Swain
Salisbury NHS Foundation Trust · GBBournemouth University · GBHampshire Hospitals NHS Foundation Trust · GBLiverpool John Moores University · GBOrthopaedic Research · GBSaveetha University · INUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rehabilitation of patients with COVID-19 after prolonged treatment in the intensive care unit is often complex and challenging. Patients may develop a myriad of long-term multiorgan impairments, affecting the respiratory, cardiac, neurological, digestive and musculoskeletal systems. Skeletal muscle dysfunction of respiratory and limb muscles, commonly referred to as intensive care unit acquired weakness, occurs in approximately 40% of all patients admitted to intensive care. The impact on mobility and return to activities of daily living is severe. Furthermore, many patients experience ongoing symptoms of fatigue, weakness and shortness of breath, in what is being described as "long COVID". Neuromuscular electrical stimulation is a technique in which small electrical impulses are applied to skeletal muscle to cause contractions when voluntary muscle contraction is difficult or impossible. Neuromuscular electrical stimulation can prevent muscle atrophy, improve muscle strength and function, maintain blood flow and reduce oedema. This review examines the evidence, current guidelines, and proposed benefits of using neuromuscular electrical stimulation with patients admitted to the intensive care unit. Practical recommendations for using electrical muscle stimulation in patients with COVID-19 are provided, and suggestions for further research are proposed. Evidence suggests NMES may play a role in the weaning of patients from ventilators and can be continued in the post-acute and longer-term phases of recovery. As such, NMES may be a suitable treatment modality to implement within rehabilitation pathways for COVID-19, with consideration of the practical and safety issues highlighted within this review.

Indexed as

Clinical Trials as TopicCOVID-19Electric Stimulation TherapyHospitalizationHumansIntensive Care UnitsRandomized Controlled Trials as TopicSARS-CoV-2coronavirus infectionCOVID-19critical caremuscular atrophyneuromuscular electrical stimulationrehabilitation

Identifiers

PMID33634830
PMCPMC8814855
OpenAlexW3130768220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.